Assertio Therapeutics, Inc.
Uradni registerski podatki
0sledilcev
2018ustanovljeno
O Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Sedež251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Ustanovljeno2018
StatusAktivno
Patenti1 patent
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Ocene
Mnenj še ni. Ste sodelovali s Assertio Therapeutics, Inc.? Bodite prvi, ki deli izkušnjo.
Pravne informacije
| Pravno ime | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Ogled na GLEIF ↗ |
| Registrirani naslov | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Status | Aktivno |
Viri: GLEIF · posodobljeno 16. oktober 2026
Stik in povezave
Lokacija
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Je to vaše podjetje?
To stran brezplačno prevzemite, da dodate logotip, izdelke, fotografije in zaposlitve ter odgovorite na mnenja.
Prevzemite to stranPridružite se Heelky, da se povežete, zaposlite in rastete
Ustvarite brezplačen račun, da ljudem pišete, se prijavljate na zaposlitve in objavljate misije.
Pridruži se zdaj — brezplačno je